GE

Genexine

Seongnam, South Korea

About

Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-acting biologics. Our goal is to bring to patients medicines that will transform their lives.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 116 investors are based in Seongnam, Kyonggi-do, South Korea.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

re•••••@genexine.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Genexine

Search Investors